Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Sunesis Pharmaceuticals (SNSS) Prices of $20 Million Offering of Common Stock, Warrants
-
Sunesis Announces Pricing of $20 Million Offering of Securities
-
Sunesis Pharmaceuticals (SNSS) to Offer Common Stock, Preferred Stock and Warrants
-
Sunesis Announces Proposed Public Offering of Common Stock, Preferred Stock and Warrants
-
Sunesis Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference
-
Sunesis Announces Closing of Public Offerings and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Sunesis Pharmaceuticals (SNSS) Prices Aggregate $25M Common Stock, Conv. Preferred Stock Offerings
-
Sunesis Announces Pricing of $25 Million Offering of Securities
-
Sunesis Pharmaceuticals (SNSS) to Offer Common Stock
-
Sunesis Announces Proposed Public Offering of Common Stock and Preferred Stock
-
Sunesis Pharmaceuticals to Present at the Cowen and Company 36th Annual Health Care Conference
-
Sunesis Announces Closing of $26 Million Offering of Securities and Exercise of Underwriter’s Over-Allotment Option
-
Sunesis Pharmaceuticals (SNSS) Prices $25M Common, Conv. Preferred Offering
-
Sunesis Announces Pricing of $25 Million Offering of Securities
-
Cowen Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Market Perform
-
Sunesis Pharma (SNSS) Prices $43M Common Stock + Warrants Offering
-
Sunesis Announces Pricing of a $43.0 Million Public Offering of Common Stock and Warrants
-
Sunesis Pharmaceuticals (SNSS) Plans Common, Warrants Offering
-
Sunesis Announces Proposed Public Offering of Common Stock and Warrants
-
Unusual 11 Mid-Day Movers 06/06: (ADES) (ZN) (COOL) Higher; (EXEL) (SNSS) (BAP) Lower
-
Sunesis Pharma (SNSS) Prices 44.1M Unit Offering at $0.35/Unit

